6月5日，冠昊生物今日收盘16.54元，下跌1.25%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到157.24倍，总市值43.86亿元。 最新一期业绩显示，2025年一季报，公司实现营业收入9479.71万元，同比3.67%；净利润1486.61万 元，同比3.30%，销售毛利率77.05%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)112冠昊生物157.24159.967.8743.86亿行业平均 50.9748.964.68108.42亿行业中值36.6736.602.4749.87亿1天益医疗-1782.30-3052.891.9022.71亿2澳华内 镜-692.58347.365.5572.99亿3诺唯赞-414.64-490.412.2788.73亿4爱朋医疗-382.20290.364.6031.36亿5博晖 创新-331.28525.693.5448.61亿6奥精医疗-149.94-219.761.9827.83亿7硕世生物-138.80-2028.201.2440.60亿 8睿昂基因-101.98-83.721.4513.20亿9康泰医学-86.93-73.4 ...

最新一期业绩显示，2025年一季报，公司实现营业收入9479.71万元，同比3.67%；净利润1486.61万 元，同比3.30%，销售毛利率77.05%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)110冠昊生物131.67133.956.5936.72亿行业平均 49.1147.374.60105.87亿行业中值35.8936.632.3948.39亿1天益医疗-1748.54-2995.051.8722.28亿2澳华内 镜-629.96315.965.0566.39亿3诺唯赞-396.80-469.312.1884.92亿4爱朋医疗-348.40264.684.2028.59亿5博晖 创新-323.49513.323.4547.46亿6硕世生物-133.76-1954.591.2039.13亿7奥精医疗-130.30-190.981.7224.18亿 8睿昂基因-100.25-82.311.4212.98亿9康泰医学-86.69-73.243.0957.06亿10中红医疗-72.51-57.830.9250.39亿 11华大智造-56.78-50.383.91302.72亿 来源：金融界 5 ...

Company Overview - Guanhao Biological Technology Co., Ltd. focuses on developing new products and technologies with independent intellectual property rights, aiming to enhance product quality and optimize product structure as core drivers of development [2] - The company operates in three main business segments: biomaterials, pharmaceuticals, and cells, and is committed to improving brand influence and market share [2] Financial Performance - For Q1 2025, the company reported revenue of 94.79 million yuan, a year-on-year increase of 3.67%, and a net profit of 14.87 million yuan, also up by 3.30%, with a gross profit margin of 77.05% [2] - The current stock price is 13.45 yuan, with a rolling PE ratio of 127.86, marking a new low in 30 days, and a total market capitalization of 3.566 billion yuan [1] Market Position - In the medical device industry, the average PE ratio is 49.51, and the median is 36.17, placing Guanhao Biological at the 110th position in terms of PE ratio [1][3] - As of May 9, 2025, the number of shareholders is 28,900, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]